Summary
Cigna Group (CI) filed an 8-K on April 27, 2026, reporting the outcomes of its Annual Meeting of Shareholders held on April 22, 2026. The meeting saw a strong turnout, with approximately 90% of outstanding shares represented. Key outcomes include the overwhelming approval of the twelve director nominees for one-year terms, indicating shareholder confidence in the current board leadership. Additionally, shareholders provided advisory approval for the company's executive compensation plan and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for 2026, both by significant margins. However, a shareholder proposal concerning the right to act by written consent narrowly failed to gain majority support. This proposal received more votes against than for, suggesting a divergence of opinion on this specific governance matter. Overall, the results reflect strong shareholder support for the company's leadership and financial oversight, while also highlighting a debate around certain corporate governance aspects.
Key Highlights
- 1Shareholders overwhelmingly elected all twelve director nominees for one-year terms.
- 2Advisory vote on executive compensation received strong shareholder approval.
- 3Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 was ratified with significant support.
- 4High shareholder participation rate of approximately 90% of outstanding shares.
- 5A shareholder proposal seeking the right to act by written consent was narrowly defeated.
- 6The majority of director nominees received over 210 million 'For' votes.